Table 6.
Univariate and multivariate Cox regression analyses of overall survival
| Univariate analysis | Multivariate model adjusted for age | ||||||
|---|---|---|---|---|---|---|---|
| n | 5-year rate | 95% CI | p** | Hazard ratio | 95% CI | p | |
| All | 2158 | 81.3 | 79.7–82.9 | ||||
| Age (years | |||||||
| < 65 | 1079 | 88.3 | 86.3–90.3 | ||||
| ≥ 65 | 1079 | 74.4 | 71.9–76.9 | < 0.001 | |||
| Sex | |||||||
| Male | 1351 | 80.2 | 78.0–82.4 | 1.0 | |||
| Female | 807 | 83.2 | 80.7–85.7 | 0.001 | 0.8 | 0.7–0.9 | 0.002 |
| ASA* | |||||||
| ASA I-II | 1498 | 85.2 | 83.4–87.0 | 85.2 | 1.0 | ||
| ASA III-IV | 336 | 63.6 | 58.3–68.9 | 63.6 | 1.9 | 1.6–2.3 | < 0.001 |
| Tumour site | |||||||
| Colon | 990 | 82.5 | 80.1–84.9 | ||||
| Rectum | 1168 | 80.3 | 77.9–82.7 | 0.306 | |||
| Stage (UICC) | |||||||
| Stage I | 573 | 88.2 | 85.5–90.9 | 1.0 | |||
| Stage II | 535 | 81.7 | 78.4–85.0 | 1.2 | 1.0–1.5 | 0.120 | |
| Stage III | 500 | 70.9 | 66.8–75.0 | 1.7 | 1.3–2.0 | < 0.001 | |
| Stage y0 | 73 | 98.6 | 95.9–100 | 0.7 | 0.4–1.3 | 0.290 | |
| Stage yI | 164 | 94.4 | 90.9–97.9 | 0.9 | 0.6–1.3 | 0.504 | |
| Stage yII | 146 | 74.6 | 67.3–81.9 | 1.8 | 1.3–2.4 | < 0.001 | |
| Stage yIII | 167 | 73.5 | 66.8–80.2 | < 0.001 | 2.3 | 1.7–3.0 | < 0.001 |
| Clavien-Dindo classification | |||||||
| 0 | 1691 | 83.5 | 81.7–85.3 | 1.0 | |||
| I | 141 | 76.2 | 69.1–93.3 | 1.6 | 1.2–2.1 | < 0.001 | |
| II | 162 | 72.7 | 65.8–79.6 | 1.5 | 1.2–1.9 | 0.001 | |
| III | 112 | 76.5 | 68.7–84.3 | 1.4 | 1.1–2.0 | 0.022 | |
| IV | 52 | 63.1 | 50.0–76.2 | < 0.001 | 1.9 | 1.3–2.7 | 0.001 |
ASA American Society of Anesthesiologists Classification; *ASA missing in 324 patients
**Log-rank test